Multiplex Newborn Screening for Pompe, Fabry, Hunter, Gaucher, and Hurler Diseases Using a Digital Microfluidic Platform

PURPOSE: New therapies for lysosomal storage diseases (LSDs) have generated interest in screening newborns for these conditions. We present performance validation data on a digital microfluidic platform that performs multiplex enzymatic assays for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases....

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Sista, Ramakrishna S., Wang, Tong, Wu, Ning, Graham, Carrie, Eckhardt, Allen, Winger, Theodore, Srinivasan, Vijay, Bali, Deeksha, Millington, David S., Pamula, Vamsee K.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3926752/
https://ncbi.nlm.nih.gov/pubmed/23660237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cca.2013.05.001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak